Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0THWMW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Chimeric anti TRBC1-SG3249
|
|||||
| Synonyms |
Chimeric anti TRBC1-SG3249
Click to Show/Hide
|
|||||
| Organization |
The Johns Hopkins University School of Medicine.; Howard Hughes Medical Institute.; Johns Hopkins University.; Genentech.; Merck and Co.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.77
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
T cell receptor beta-chain constant region 1 (TRBC1)
|
Antigen Info | ||||
| Payload Name |
SG3199
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
CL2A
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
SG3249
|
|||||